| Product Code: ETC13348273 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Prostate-Specific Antigen Blood-Based Biomarker Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Prostate-Specific Antigen Blood-Based Biomarker Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume, 2021 & 2031F |
3.3 North America Prostate-Specific Antigen Blood-Based Biomarker Market - Industry Life Cycle |
3.4 North America Prostate-Specific Antigen Blood-Based Biomarker Market - Porter's Five Forces |
3.5 North America Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 North America Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.8 North America Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume Share, By Test Sensitivity, 2021 & 2031F |
3.9 North America Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume Share, By End Use, 2021 & 2031F |
3.10 North America Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume Share, By Distribution, 2021 & 2031F |
4 North America Prostate-Specific Antigen Blood-Based Biomarker Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Prostate-Specific Antigen Blood-Based Biomarker Market Trends |
6 North America Prostate-Specific Antigen Blood-Based Biomarker Market, 2021 - 2031 |
6.1 North America Prostate-Specific Antigen Blood-Based Biomarker Market, Revenues & Volume, By Application, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Prostate-Specific Antigen Blood-Based Biomarker Market, Revenues & Volume, By Diagnostic Testing, 2021 - 2031 |
6.1.3 North America Prostate-Specific Antigen Blood-Based Biomarker Market, Revenues & Volume, By Screening, 2021 - 2031 |
6.1.4 North America Prostate-Specific Antigen Blood-Based Biomarker Market, Revenues & Volume, By Prognostic Testing, 2021 - 2031 |
6.1.5 North America Prostate-Specific Antigen Blood-Based Biomarker Market, Revenues & Volume, By Monitoring, 2020 - 2028 |
6.2 North America Prostate-Specific Antigen Blood-Based Biomarker Market, Revenues & Volume, By Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Prostate-Specific Antigen Blood-Based Biomarker Market, Revenues & Volume, By Serum PSA, 2021 - 2031 |
6.2.3 North America Prostate-Specific Antigen Blood-Based Biomarker Market, Revenues & Volume, By Free PSA, 2021 - 2031 |
6.2.4 North America Prostate-Specific Antigen Blood-Based Biomarker Market, Revenues & Volume, By Total PSA, 2021 - 2031 |
6.2.5 North America Prostate-Specific Antigen Blood-Based Biomarker Market, Revenues & Volume, By Complex PSA, 2021 - 2031 |
6.3 North America Prostate-Specific Antigen Blood-Based Biomarker Market, Revenues & Volume, By Test Sensitivity, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Prostate-Specific Antigen Blood-Based Biomarker Market, Revenues & Volume, By High Sensitivity, 2021 - 2031 |
6.3.3 North America Prostate-Specific Antigen Blood-Based Biomarker Market, Revenues & Volume, By Low Sensitivity, 2021 - 2031 |
6.3.4 North America Prostate-Specific Antigen Blood-Based Biomarker Market, Revenues & Volume, By Specificity, 2021 - 2031 |
6.4 North America Prostate-Specific Antigen Blood-Based Biomarker Market, Revenues & Volume, By End Use, 2021 - 2031 |
6.4.2 North America Prostate-Specific Antigen Blood-Based Biomarker Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.3 North America Prostate-Specific Antigen Blood-Based Biomarker Market, Revenues & Volume, By Clinics, 2021 - 2031 |
6.4.4 North America Prostate-Specific Antigen Blood-Based Biomarker Market, Revenues & Volume, By Diagnostic Centers, 2020 - 2028 |
6.5 North America Prostate-Specific Antigen Blood-Based Biomarker Market, Revenues & Volume, By Distribution, 2020 - 2028 |
6.5.1 Overview & Analysis |
6.5.2 North America Prostate-Specific Antigen Blood-Based Biomarker Market, Revenues & Volume, By Direct-to-Consumer, 2020 - 2028 |
6.5.3 North America Prostate-Specific Antigen Blood-Based Biomarker Market, Revenues & Volume, By Pharmacies, 2020 - 2028 |
6.5.4 North America Prostate-Specific Antigen Blood-Based Biomarker Market, Revenues & Volume, By Hospitals, 2020 - 2028 |
7 North America Prostate-Specific Antigen Blood-Based Biomarker Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Prostate-Specific Antigen Blood-Based Biomarker Market, Revenues & Volume, By Application, 2021 - 2031 |
7.2.1 United States (US) Prostate-Specific Antigen Blood-Based Biomarker Market, Revenues & Volume, By Application, 2021 - 2031 |
7.2.2 Canada Prostate-Specific Antigen Blood-Based Biomarker Market, Revenues & Volume, By Application, 2021 - 2031 |
7.2.3 Rest of North America Prostate-Specific Antigen Blood-Based Biomarker Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3 North America Prostate-Specific Antigen Blood-Based Biomarker Market Revenues & Volume Share, By Type, 2021 & 2031F |
7.3.1 United States (US) Prostate-Specific Antigen Blood-Based Biomarker Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3.2 Canada Prostate-Specific Antigen Blood-Based Biomarker Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3.3 Rest of North America Prostate-Specific Antigen Blood-Based Biomarker Market, Revenues & Volume, By Type, 2021 - 2031 |
7.4 North America Prostate-Specific Antigen Blood-Based Biomarker Market, Revenues & Volume, By Test Sensitivity, 2021 - 2031 |
7.4.1 United States (US) Prostate-Specific Antigen Blood-Based Biomarker Market, Revenues & Volume, By Test Sensitivity, 2021 - 2031 |
7.4.2 Canada Prostate-Specific Antigen Blood-Based Biomarker Market, Revenues & Volume, By Test Sensitivity, 2021 - 2031 |
7.4.3 Rest of North America Prostate-Specific Antigen Blood-Based Biomarker Market, Revenues & Volume, By Test Sensitivity, 2021 - 2031 |
7.5 North America Prostate-Specific Antigen Blood-Based Biomarker Market, Revenues & Volume, By End Use, 2021 - 2031 |
7.5.1 United States (US) Prostate-Specific Antigen Blood-Based Biomarker Market, Revenues & Volume, By End Use, 2021 - 2031 |
7.5.2 Canada Prostate-Specific Antigen Blood-Based Biomarker Market, Revenues & Volume, By End Use, 2021 - 2031 |
7.5.3 Rest of North America Prostate-Specific Antigen Blood-Based Biomarker Market, Revenues & Volume, By End Use, 2021 - 2031 |
7.6 North America Prostate-Specific Antigen Blood-Based Biomarker Market, Revenues & Volume, By Distribution, 2021 - 2031 |
7.6.1 United States (US) Prostate-Specific Antigen Blood-Based Biomarker Market, Revenues & Volume, By Distribution, 2021 - 2031 |
7.6.2 Canada Prostate-Specific Antigen Blood-Based Biomarker Market, Revenues & Volume, By Distribution, 2021 - 2031 |
7.6.3 Rest of North America Prostate-Specific Antigen Blood-Based Biomarker Market, Revenues & Volume, By Distribution, 2021 - 2031 |
8 North America Prostate-Specific Antigen Blood-Based Biomarker Market Key Performance Indicators |
9 North America Prostate-Specific Antigen Blood-Based Biomarker Market - Export/Import By Countries Assessment |
10 North America Prostate-Specific Antigen Blood-Based Biomarker Market - Opportunity Assessment |
10.1 North America Prostate-Specific Antigen Blood-Based Biomarker Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Prostate-Specific Antigen Blood-Based Biomarker Market Opportunity Assessment, By Application, 2021 & 2031F |
10.3 North America Prostate-Specific Antigen Blood-Based Biomarker Market Opportunity Assessment, By Type, 2021 & 2031F |
10.4 North America Prostate-Specific Antigen Blood-Based Biomarker Market Opportunity Assessment, By Test Sensitivity, 2021 & 2031F |
10.5 North America Prostate-Specific Antigen Blood-Based Biomarker Market Opportunity Assessment, By End Use, 2021 & 2031F |
10.6 North America Prostate-Specific Antigen Blood-Based Biomarker Market Opportunity Assessment, By Distribution, 2021 & 2031F |
11 North America Prostate-Specific Antigen Blood-Based Biomarker Market - Competitive Landscape |
11.1 North America Prostate-Specific Antigen Blood-Based Biomarker Market Revenue Share, By Companies, 2022 |
11.2 North America Prostate-Specific Antigen Blood-Based Biomarker Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here